Short answer
AbbVie Inc (ABBV) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 8.01 (Other Events). $10.0B senior-notes offering across maturities from 2028 to 2066, supporting Apogee acquisition funding.
AbbVie Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $10.0B senior-notes offering across maturities from 2028 to 2066, supporting Apogee acquisition funding
- Net proceeds approximately $9.93B after underwriting discounts and estimated expenses
- Coupon rates range from 4.500% to 6.100%, creating substantial long-term interest obligations
- Proceeds reduce commitments under AbbVie’s $10.0B 364-day delayed-draw term loan facility
- Closing expected August 18, 2026, subject to customary conditions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AbbVie Inc 8-K filings
Get the next ABBV 8-K as it lands
Follow ABBV for push alerts, or ask the research agent what this filing means.